American Society of Clinical Oncology

With three more ASCO meetings this year, there are still plenty of opportunities to connect with peers, discover groundbreaking cancer research, & gain clinical insights. Don't miss out on our meetings—the ultimate Place to Be. Where will we see you this year?

Test your clinical knowledge with a ❓ from our ASCO-SEP Question Bank!  Q: Patient (72) starts a TKI for FGFR3-altered urothelial cancer. Next step? 1️⃣ Lung function test 2️⃣ Echocardiogram 3️⃣ Hemoglobin A1C 4️⃣ Ophthalmologic exam 📊 Show results

Test your clinical knowledge with a ❓ from our ASCO-SEP Question Bank! Q: Patient (72) starts a TKI for FGFR3-altered urothelial cancer. Next step? A: Lung function test B: Echocardiogram C: Hemoglobin A1C D: Ophthalmologic exam

Our draft guideline protocol for “Treatment of Advanced Pancreatic Cancer: ASCO Guideline Update” are now open for public comment. Help us determine the scope of the guideline. Submit your comments to us by November 4. Read and comment: https://bit.ly/3VOeCZ6

ASCO Leads: Latin America applications open! Apply by Oct. 26 to join us in Costa Rica Feb. 11-12, 2027, for leadership training and premier networking. Designed for mid-career ASCO Members currently practicing oncology in the Latin America region. Advance your career today: https://bit.ly/4ynK1ig

Our draft guideline recommendations for “Perioperative Systemic Therapy for Non-Metastatic Renal Cell Carcinoma” are now open for public comment. Help us refine these standards of care. Submit your comments to us by November 3. Read and comment: https://bit.ly/4dIQvRx

ASCO Members! You now get full access to ASCO Meetings content just 30 days post-meeting. Explore the latest science faster and from anywhere. View content from the 2026 ASCO Annual Meeting: https://bit.ly/4hXg1DS Coming soon: An AI-powered agent from ASCO & Google Cloud to simplify your research.

Our draft guideline recommendations for “Management of Immune-Related Adverse Events- Gastrointestinal and Endocrine Toxicities” are now open for public comment. Submit your comments to us by November 2: https://bit.ly/4yn0DH2

Nominations are open for the @conquercancer.bsky.social Women Who Conquer Cancer Mentorship Award. Honor extraordinary women leaders who mentor the next generation of oncologists. Nominate a Woman Who Inspires You! Submit by Dec. 10th: https://bit.ly/47b42hb

The last session has ended, and our time at #ASCOQLTY26 has come to a close. Thank you to our incredible attendees, speakers, and patient advocates for coming together to share actionable insights, elevate care delivery, and improve outcomes for the cancer community. 🧡

A huge ‘thank-you’ to all of our wonderful #ASCOQLTY26 Featured Voices for sharing their expertise on sessions and abstracts—and bringing so much joy and enthusiasm to the meeting! 💓 @ryannipp.bsky.social

Dr. @crisbergerot.bsky.social and Dr. Angela Feraco chair a session examining systems-level care solutions & clinical models that personalize treatment for diverse pt populations, including AYAs and older adults at #ASCOQLTY26. https://bit.ly/4jOLWsE

💡Our real-world analysis showed median time to consolidative #immunotherapy of 84 days from CRT start in Stage III #NSCLC (2018-2021). Uninsured, Medicaid, and tx at non-academic center associated w/ longer time to intiation #ASCOQLTY26 @bidmc-cancercenter.bsky.social @ascocancer.bsky.social

New clinical insights from the #ASCOQLTY26 rapid oral session! 💡 Presenters are revealing how AI scribes support clinics, why screening adherence matters, and how tailored tools improve life post-treatment. Session: https://bit.ly/4rTeJOI

Happening now at #ASCOQLTY26: a “Quality Exchange” between this year’s Joseph Simone Quality Care Award winner Dr. Areej El-Jawahri and past recipients Dr. @ethanbasch.bsky.social and @drrobinyabroff.bsky.social. Session: https://bit.ly/4dyyjtL

What is the real-world role of AI in oncology? Moderated by Dr @fumikochino.bsky.social & Dr @anaikothari.bsky.social, experts are taking the stage at #ASCOQLTY26 to debate the future of artificial intelligence in cancer care balancing tech progress w vital pt-physician trust. https://bit.ly/4s2sR8I

If you’re in person with us at #ASCOQLTY26, join us this afternoon for two 15-minute demos of products that could help with your practice. Each demo will be followed by dedicated one-on-one Q&A time so you can learn more: https://bit.ly/4AQXHoO

Happening now at #ASCOQLTY26: Day 2 oral sessions are underway! 🗣️ Experts are on stage discussing the next frontier of oncology care, from debated AI workflows to innovative survivorship tools. https://bit.ly/4hEqHIO

Can exercise reduce fatigue for patients receiving immunotherapy for cancer treatment? @jrgralow.bsky.social breaks down this latest abstract from @paulobergerot.bsky.social and colleagues presented at #ASCOQLTY26: https://bit.ly/4dHAk74

💡Compelling study on feasibility of consolidative #durvalumab ≤14days after completion of definitive CRT for #NSCLC without added immune-related toxicity. Interesting contrast to TORG1937 (DATE Study) from Japan. Further food for thought for time to tx intiation #ASCOQLTY26 @ascocancer.bsky.social

Day 2 of #ASCOQLTY26 starts now! 🍳 Fuel up with a complimentary hot breakfast from 7:20-8:20 AM (ET) and jump straight into this morning’s poster session. ☕ Grab your coffee, build a plate, and join the discussion: https://bit.ly/3TmqXCW

Finishing out the day at #ASCOQLTY26 with a complimentary reception and Poster Walks led by @ethicsdoctorp.bsky.social and Dr. Charles Jiang. Speaking with presenters and learning about their research + 🧀 = perfection! Learn more: https://bit.ly/4rVlgIF

Congratulations to the 46 @conquercancer.bsky.social Merit Award winners here at #ASCOQLTY26! Such a talented bunch of early career researchers pursuing research breakthroughs for so many different types of cancer. 🎉#ResearchConquersCancer View the list of recipients: https://bit.ly/4k6vbJw

Appreciate this #ASCOQLTY26 discussion about how social media impacts patients and patient care. In my own life, I've seen how Facebook groups and Subreddits can provide important patient community. But it's so easy to forget:

Sobering, important work #ASCOQLTY26: rise in deaths pregnancy-associated deaths among people w/ cancer over past 8 years. Lots of questions needed about how the death certificate data was defined, etc - but highlights how important it is to pay attention to this at-risk group.

Physician payments & end-of-life tx: -Slight ⬆️ aggressive EOL care among those who received payments -However, is this a function of 3' centers seeing more patients at later lines of tx? -Need to clarify research support vs personal $ #ASCOQLTY26 @thewonkologist.bsky.social @dusetzinas.bsky.social

Just finished presenting these new findings at #ASCOQLTY26 Industry payments to oncologists are associated with aggressive end-of-life care for patients with cancer.

Learning about “Delivering Value in Everyday Oncology Care” right now at #ASCOQLTY26 in a session chaired by Dr. Ryan Huey and Dr. Hari Nathan: https://bit.ly/4jdqFc4

Rapid Oral Abstract Session A is underway at #ASCOQLTY26 chaired by Dr. Gabriel A. Brooks and Dr. Manisha Bhattacharya: https://bit.ly/3TPGqeJ

Have you taken time to paws and play with our #ASCOQLTY26 therapy dog? 🐾 For the furst time at one of our symposiums, we have some canine joy. 🐶 This cutie is here with us at lunch today.

Read a short #ASCODailyNews profile on Dr. El-Jawahri and her emphasis on meeting the needs of patients with blood cancers and their caregivers: bit.ly/4ypiCh1

Congratulations to Areej El-Jawahri, MD, FASCO, winner of the Joseph V. Simone Quality Care Award! 🏆This honor recognizes her multiple, significant & enduring contributions to the quality and safety of cancer care. Thank you for your leadership! #ASCOQLTY26 Session: https://bit.ly/4zqN0aV

Geriatric assessment + guided management can reduce treatment toxicity & improve quality of life for older adults with cancer, but uptake remains low, especially in certain settings. For #ASCODailyNews, @crisbergerot.bsky.social & co-authors offer a path forward: https://bit.ly/4jpV1YO #ASCOQLTY26

If you’re in person with us at #ASCOQLTY26, join us this afternoon for two 15-minute demos of products that could help with your practice. Each demo will be followed by dedicated one-on-one Q&A time so you can learn more: https://bit.ly/4AQXHoO

“Trust is paramount in #cancercare,” said 1st speaker @drteplinsky.bsky.social. How are AI, virtual peer networks & industry shifts redefining the pt-physician relationship? Join us now for “Preserving Trust as Patients, AI & Industry Redefine the Clinician’s Role.” Session: https://bit.ly/4ART9OG

While you’re here at #ASCOQLTY26, stop by our tables and learn more about membership (and get a discount), network with our Health Services Research Committee chair, learn about ASCO Certified, try new AI tools to enhance your meeting experience, and more.

New research from a large-scale, national, randomized study examines the impact of financial navigation intervention on financial distress. Dr. Joel Saltzman explains more in our latest Science in Seconds: https://bit.ly/4yxQ5VS #ASCOQLTY26

Oral Abstract Session A begins today with our Featured Voice Dr. @ryannipp.bsky.social welcoming everyone to #ASCOQLTY26! Check out what’s coming up in the session: https://bit.ly/4xpdLuK

Happening in person at #ASCOQLTY26 today only: join us at lunchtime for 2 unique networking opportunities: 🔹 Meet Health Services Research Cmte Chair Dr. Ishwaria Subbiah at the ASCO Membership Table 🔹Meet #JCOOP Editor-in-Chief Dr. Jeffrey Peppercorn at the JCO Journals Table

If you’re in person, don’t forget to stop by the complimentary hot breakfast 🍳. Fuel your body and catch up with colleagues before Oral Abstract Session A begins at 8 AM (ET): https://bit.ly/4xpdLuK If you’re online, drop a pic of your breakfast in the comments! ☕️💻

Good morning, Boston! ☀️ #ASCOQLTY26 begins today! Check out the sessions we will be covering today, and don’t forget to network at these events if you are in person. View the program or ASCO Meetings app to know when and where everything is happening: https://bit.ly/4d39BBJ

Drs. Sumanta Pal of @cityofhope.bsky.social and @stolaney1.bsky.social of @danafarber.bsky.social discuss optimizing ADCs and managing toxicities in metastatic breast cancer on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4saZIZ0

NBC's @todayshow.com highlights Dr. Rachna Shroff's cancer journey, honoring her life, clinical impact, and legacy in supporting the next generation of researchers.

🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social and Dr. Kimmie Ng of @danafarber.bsky.social discuss the concerning global rise in early-onset cancer and the critical care challenges outlined in a compelling paper in the #EdBook on the #ByTheBook podcast: https://bit.ly/4ycBY7Y

Plan #ASCOQLTY26 with ease! 📱 Explore the program, review abstracts, and check out the new ASCO Meetings Navigator—your personal guide to building a custom schedule and getting real-time logistical answers. Access it online or through the ASCO Meetings app: https://bit.ly/4hTvNAR

If you’ll be w us in Boston at #ASCOQLTY26, take in the area around the Hynes Convention Center while getting the latest data-driven research on improving the quality of cancer care delivery. If you’re a local, what else should attendees do & see in the Back Bay? Let us know! 👇

The full 700+ abstracts for #ASCOQLTY26 are now available! Check out the latest science on quality, safety, and efficiency in #CancerCare delivery. Late-breaking abstracts will be released at 7 AM (ET) on their presentation day. View the full abstracts here: https://bit.ly/3TwmKN6

Our draft guideline recommendations for “Management of Stages I-III Non-Small Cell Lung Cancer” are now open for public comment. Help us refine these standards of care. Submit your comments to us by October 26. Read and comment here: https://bit.ly/4hFkTyM

If you guessed C, you’re right! 🙌 Upstaged NSCLC needs adjuvant chemo, then immunotherapy for PD-L1 1% or higher. Subscribe to ASCO-SEP® today: bit.ly/4zrBqwc ASCO members get 20% off; additional discounts available.